UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Leukemia, 2011-02, Vol.25 (2), p.341-347

2011

Volltextzugriff (PDF)

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

Leukemia, 2017-12, Vol.31 (12), p.2791-2798

2017

Volltextzugriff (PDF)

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Annals of oncology, 2009-03, Vol.20 (3), p.449-453

2009

Volltextzugriff (PDF)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Annals of oncology, 2014-10, Vol.25 (10), p.2020-2024

2014

Volltextzugriff (PDF)

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Leukemia, 2018-03, Vol.32 (3), p.719-728

2018

Volltextzugriff (PDF)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Annals of oncology, 2019-02, Vol.30 (2), p.346-346

2019

Volltextzugriff (PDF)

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study

Leukemia, 2011-12, Vol.25 (12), p.1877-1881

2011

Volltextzugriff (PDF)

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Blood cancer journal (New York), 2018-11, Vol.8 (11), p.108-8, Article 108

2018

Volltextzugriff (PDF)

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

Blood cancer journal (New York), 2015-08, Vol.5 (8), p.e338-e338

2015

Volltextzugriff (PDF)

INTERIM PET/CT PREDICTS OUTCOMES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH FRONTLINE LENALIDOMIDE/RCHOP (R2CHOP): LONG‐TERM ANALYSIS OF MC078E

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

THE DIAL STUDY (DUAL IMMUNOMODULATION IN AGGRESSIVE LYMPHOMA): RANDOMIZED PHASE 2 TRIAL OF VARLILUMAB PLUS NIVOLUMAB IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL LYMPHOMAS

Hematological oncology, 2019-06, Vol.37 (S2), p.70-71

2019

Volltextzugriff (PDF)

Small intestinal obstruction by sunflower seed bezoar

Journal of pediatric surgery case reports, 2019-07, Vol.46, p.101215-101215, Article 101215

2019

Volltextzugriff (PDF)

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e528-e528

2017

Volltextzugriff (PDF)

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e576-e576

2017

Volltextzugriff (PDF)

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.201-205

2014

Volltextzugriff (PDF)

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e526-e526

2017

Volltextzugriff (PDF)

Standardized irrigation technique reduces intraabdominal abscess after appendectomy

Journal of pediatric surgery, 2019-04, Vol.54 (4), p.728-732

2019

Volltextzugriff (PDF)

Peritoneal dialysis catheter placement, outcomes and complications

Pediatric surgery international, 2018-11, Vol.34 (11), p.1239-1244

2018

Volltextzugriff (PDF)

Combined laparoscopic-fluoroscopic technique for primary gastrojejunostomy button tube placement

Journal of pediatric surgery, 2019-04, Vol.54 (4), p.862-865

2019

Volltextzugriff (PDF)

The universal remote console: a universal access bus for pervasive computing

IEEE pervasive computing, 2004-01, Vol.3 (1), p.76-80

2004

Volltextzugriff (PDF)

5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S250-S250

2011

Volltextzugriff (PDF)

The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer

Diseases of the esophagus, 2006-08, Vol.19 (4), p.241-247

2006

Volltextzugriff (PDF)

5.11 Lenalidomide Consolidation Seems to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S249-S249

2011

Volltextzugriff (PDF)

Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma

American journal of hematology, 2014-12, Vol.89 (12), p.E223-E227

2014

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Humans
(38)
Female
(34)
Male
(32)
Aged
(29)
Middle Aged
(28)
Hematology
(24)
Oncology
(22)
Aged, 80 And Over
(21)
Adult
(17)
Treatment Outcome
(15)
Immunotherapy
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Lymphoma
(11)
Disease-Free Survival
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Prognosis
(9)
Targeted Cancer Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

INTERIM PET/CT PREDICTS OUTCOMES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH FRONTLINE LENALIDOMIDE/RCHOP (R2CHOP): LONG‐TERM ANALYSIS OF MC078E

THE DIAL STUDY (DUAL IMMUNOMODULATION IN AGGRESSIVE LYMPHOMA): RANDOMIZED PHASE 2 TRIAL OF VARLILUMAB PLUS NIVOLUMAB IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL LYMPHOMAS

Small intestinal obstruction by sunflower seed bezoar

Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

Standardized irrigation technique reduces intraabdominal abscess after appendectomy

Peritoneal dialysis catheter placement, outcomes and complications

Combined laparoscopic-fluoroscopic technique for primary gastrojejunostomy button tube placement

The universal remote console: a universal access bus for pervasive computing

5.12 Ofatumumab-Based Chemoimmunotherapy for Patients With Previously Untreated Chronic Lymphocytic Leukemia

The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer

5.11 Lenalidomide Consolidation Seems to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated Chronic Lymphocytic Leukemia

Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Suchergebnisse filtern